DelveInsight Blogs Sitemap

All Posts in this category
S.No. Product Name Actions
1 Sky Medical’s Geko™ device; Fist Assist Devices obtains Breakthrough Device designation; Edwards obtains FDA approval; BD launched instrument for testing; GE acquires BK Medical; Zynex’ CM-1500; Foldax’s TRIA biopolymer heart valve Visit Post
2 Aslan Pharma - IQVIA collaboration; Reata's kidney drug bardoxolone; Alzheimer’s Disease treatment update; Recordati to acquire EUSA Visit Post
3 AstraZeneca's Ultomiris; HebaBiz's Siroquine; Pfizer's XELJANZ; Bristol Myers Squibb's Opdivo; and Masimo's PVi Visit Post
4 Fight Against the Antibiotic Resistance in the Uncomplicated Urinary Tract Infections Market Visit Post
5 BlueRock secures FDA fast track; Omniscient rakes in $29M; Neuspera’s nerve implant gets a $65M boost Rivus’ therapy nabs $35M Visit Post
6 Bayer's CKD Drug; Enochian’s RNA Hijack for HBV; Novo Nordisk's to get Prothena's ATTR Amyloidosis Business; J&J’s COVID-19 Vaccine Struggle Visit Post
7 Horizon/ Arrowhead Deal; Dr Reddy's Lab’s Drug US Launch; Targovax’s ONCOS-102; RedHill's Oral Opaganib in COVID-19 Visit Post
8 Renal Tubular Acidosis Therapy Market and Sub-Optimally Effective Standard of Care Visit Post
9 Market Heats Up as Managing Benign Prostatic Hyperplasia Through Devices Gains Traction Visit Post
10 Merck, Eisai in renal cancer market; G1 Therapeutics on Cosela’s approval; Takeda's Maribavir; Astellas/Seagen Padcev Visit Post
11 A Globally Rising Burden of Sexually Transmitted Diseases (STDs) Visit Post
12 Nestle to acquire Aimmune Therapeutics; Vir Bio & GSK's COVID-19 monoclonal antibody therapy; AstraZeneca's Farxiga scores goal in Phase III CDK trial Visit Post
13 Interstitial Cystitis: A big opportunities for emerging drugs Visit Post
14 Watch Out for the Most Promising Therapies in the Pipeline in Acute Kidney Injury Market Visit Post
15 Emerging Therapies that can significantly impact the Acute Kidney Injury Market Visit Post
16 Novome raises USD 33M, Buyout of Bioniz, Adagene raises USD 69M Visit Post
17 Autologous cell therapy market: A new paradigm for kidney diseases Visit Post
18 GHO to advance healthcare in Europe; Truvian nets USD 27.1 Mn; Lilly plans its diabetes portfolio expansion Visit Post
19 World Kidney Day Visit Post
20 WORLD AIDS DAY - 2018 Visit Post
21 Calciphylaxis: Rare Yet Potentially Fatal Visit Post
22 Notizia Visit Post
23 Notizia Visit Post
24 Hyperuricemia – Uric acid disorder, a gateway to other diseases Visit Post
25 The Business Cocktail : Latest Pharma deals Visit Post
26 Teva sells generics; Valeant trades; Roche's Genentech; J&J's next potential frontier Visit Post
27 Interstitial Cystitis : Promising Scope for Research Visit Post
28 Urinary Tract Infections (UTIs)– How is it affecting the Globe? Visit Post
29 Invokana matches; Xultophy beats; Lilly and BI follow; Tresiba matches Visit Post
30 Insight on Interstitial Cystitis- The Bladder Pain Syndrome Visit Post
31 Urinary Incontinence: Epidemiology Insight on Leaking Bladder Visit Post
32 The Current Scenario for Interstitial Cystitis(IC) Visit Post
33 USFDA warns; Vit B3 prevents glaucoma; Zydus Cadila receives nod; U.S. experts soften on DNA editing Visit Post
34 Chronic Kidney Disease: Complex Debilitating Condition Visit Post
35 mTOR Inhibitors-Emerging therapy in various therapeutic areas Visit Post
36 Bayer AG & Evotec AG’s deal; Plasticell and CellSpring AG’s deal; Allergan Acquires Akarna; Cambrex Acquires Pharmacore Visit Post
37 DelveInsight’s Genitourinary Sex hormones based Gene Therapy Reports Visit Post
38 Metastatic Prostate Cancer-Pipeline Insights, 2014 Visit Post